Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Germany,Poland,United States,France,Bulgaria,Italy,Latvia,Hungary,Romania,Australia
nct
Update Il y a 5 ans
A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate
This study is a Phase 2 randomized, double-blind, double-dummy, active- and placebo-controlled, parallel-group study designed to assess the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of multiple doses of ABT-122 in subjects with active psoriatic arthritis (PsA) who are inadequately responding to methotrexate (MTX) treatment.
Country
Australia
,
Bulgaria
,
Czech Republic
,
France
,
Germany
,
Hungary
,
Italy
,
Latvia
,
New Zealand
,
Poland
,
Romania
,
Spain
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1